Review pharmacologic treatment of psychiatric disease in pregnancy and lactation: Fetal and neonatal effects

Obstetrics and Gynecology

Volumn 87, Issue 5, 1996, Pages 789-794

  Kuller, Jeffrey A ^a   Katz, Vern L ^a   McMahon, Michael J ^a   Wells, Steven R ^a   Bashford, Robert A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CHLORPROMAZINE; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; NEUROLEPTIC AGENT; PEMOLINE; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; ANXIETY NEUROSIS; BIRTH DEFECT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MILK LEVEL; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; FEMALE; FETUS; FETUS DEVELOPMENT; HUMAN; IRRITABILITY; LACTATION; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MATERNAL HYPERTENSION; NERVOUSNESS; NEWBORN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PSYCHOTHERAPY; PUERPERAL DEPRESSION; REVIEW; SCHIZOPHRENIA; SPONTANEOUS ABORTION; TERATOGENICITY; URINE RETENTION;

ABNORMALITIES, DRUG-INDUCED; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; LACTATION; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; PUERPERAL DISORDERS;

EID: 0029929263     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00479-9     Document Type: Article

References (38)

1. American College of Obstetricians and Gynecologists. Depression in women. ACOG technical bulletin no. 182. Washington, DC: American College of Obstetricians and Gynecologists, 1993.
2. Pickar D. Prospects for pharmacotherapy of schizophrenia. Lancet 1995;345:557-62.
3. Myers JK, Weissman MM, Tischler CL, Holzer CE, Leaf PJ, Orvaschel H, et al. Six-month prevalence of psychiatric disorders in three communities; 1980 to 1982. Arch Gen Psychiatry 1984;41: 959-67.
4. McGrath E, Ketia GP, Strickland BR, Russo NF. Women and depression: Risk factors and treatment issues. Washington, DC: American Psychological Association, 1990.
5. Altshuler LL, Szuba MP. Course of psychiatric disorders in pregnancy: Dilemmas in pharmacologic management. Neurol Clin 1994;12:613-35.
6. Goldberg HL, Nissim R. Psychotropic drugs in pregnancy and lactation. Int J Psychiatry Med 1994;24:129-49.
7. Sitland-Marken P, Rickman LA, Wells BG, Mabie WC. Management of acute mania in pregnancy. J Clin Psychopharmacol 1989; 9:78-87.
8. Idanpaan-Keikkila J, Saxen I. Possible teratogenecity of imipramine/chloropyramine. Lancet 1973;2:282-4.
9. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269:2246-8.
10. Briggs GG, Freeman RK, Yaffee SJ, eds. Drugs in pregnancy and lactation. 4th ed. Baltimore, Maryland: Williams & Wilkins, 1994.
11. Chiarello RJ, Cole JO. The use of psychostimulants in general psychiatry. Arch Gen Psychiatry 1987;44:286-95.
12. Repke JT, Berger NG. Electroconvulsive therapy in pregnancy. Obstet Gynecol 1984;63:39S-41S.
13. Sobel DE. Fetal damage due to ECT, insulin coma, chlorpromazine or reserpine. Arch Gen Psychiatry 1960;2:606-11.
14. Sherer DM, D'Amico ML, Warshal DP, Stern RA, Grunert HF, Abramowicz JS. Recurrent mild abruptio placentae occurring immediately after repeated electroconvulsive therapy in preg¬nancy. Am J Obstet Gynecol 1991;165:652-3.
15. Lam RW, Kripke DF, Gillin JC. Phototherapy for depressive disorders: A review. Can J Psychiatry 1989;34:140-7.
16. Wu JC, Bunney WE. The biologic basis of antidepressant response to sleep deprivation and relapse. Am J Psych 1990;147:14-21.
17. Schou M, Goldfield MD, Weinstein MR, Villeneuve A. Lithium and pregnancy, 1: Report from the register of lithium babies. BMJ 1973;2:135-6.
18. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992;339:530-3.
19. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A réévaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146-50.
20. Krause S, Ebbesen F, Lange A. Polyhydramnios with maternal lithium treatment. Obstet Gynecol 1990;75:504-6.
21. Ang MS, Thorp JA, Parisi VM. Maternal lithium therapy and polyhydramnios. Obstet Gynecol 1990;76:517-9.
22. Delgado-Escueta AV, Janz D. Consensus guidelines: Preconception counseling, management, and care of pregnant woman with epilepsy. Neurology 1992;42(suppl 5):149-60.
23. Rosa FW. Spina bifida in infants of women treated with carba¬mazepine during pregnancy. N Engl J Med 1991;324:674-7.
24. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320:1661-6.
25. Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994;271:767-70.
26. Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990;322:1567-72.
27. Ayd FJ. Haloperidol: Fifteen years of clinical experience. Dis Nerv Syst 1972;33:459-69.
28. Kerns LL. Treatment of mental disorders in pregnancy—A review of psychotropic drug risks and benefits. J Clin Psychopharmacol 1989;9:78-87.
29. Rumeau-Rouquette C, Goujard J, Huel G. Possible teratogenic effects of phenothiazines in human beings. Teratology 1977;15:57-64.
30. Edlund MJ, Craig TJ. Antipsychotic drug use and birth defects: An epidemiologic reassessment. Compr Psychiatry 1994;25:32-8.
31. Auerbach JG, Hans SL, Marcus J, Maeir S. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 1992;14: 399-406.
32. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, Shapiro S. Lack of relation of oral clefts to diazepan use during pregnancy. N Engl J Med 1983;309:1282-5.
33. Bergman U, Rosa FW, Baum C, Wiholm BE, Gaich GA. Effects of exposure to benzodiazepine during fetal life. Lancet 1992;340: 694-6.
34. St Clair SM, Schirmer RG. First-trimester exposure to alprazolam. Obstet Gynecol 1992;80:843-6.
35. Pons G, Rev E, Matheson I. Excretion of psychoactive drugs into breast milk: Pharmacokinetic principles and recommendations. Clin Pharmacokinet 1994;27:270-89.
36. Stewart RB, Karas B, Springer PK. Haloperidol excretion in human milk. Am J Psychiatry 1980;137:849-50.
37. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-50.
38. Hytten FE, Chamberlain GV, eds. Clinical physiology in obstetrics. Oxford, United Kingdom: Blackwell, 1980:163-233.